Four investments form Arch Venture Becker’s has covered since Sept. 13:
- Arch Venture co-led the $18 million series A funding round for Protillion Biosciences. The company works to optimize and identify new protein therapeutics, according to a Dec. 19 Protillion news release.
- Arch led the $75 million series C financing round for Synchron, a brain-computer interface company. Bezos Expeditions, the investment firm of Amazon founder Jeff Bezos, and Gates Frontier, Microsoft founder Bill Gates’ investment fund, joined in the round.
- Arch and General Catalyst co-led a $32 million seed funding round for Rippl, a mental health tech company focused on the needs of older patients.
- Arch co-led a $72.5 million series A funding round for Pretzel Therapeutics, a company that uses mitochondrial biology to treat disease.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
